Shanghai Sanyou Medical Co Ltd (688085) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shanghai Sanyou Medical Co Ltd (688085) has a cash flow conversion efficiency ratio of 0.016x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥34.19 Million ≈ $5.00 Million USD) by net assets (CN¥2.10 Billion ≈ $306.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 688085 net asset quality index to measure how much of total assets are equity-financed.
Shanghai Sanyou Medical Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Shanghai Sanyou Medical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 688085 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Shanghai Sanyou Medical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Sanyou Medical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
LifeSemantics Corp.
KQ:347700
|
-0.313x |
|
Helen of Troy Ltd
NASDAQ:HELE
|
-0.001x |
|
Jana Small Finance Bank
NSE:JSFB
|
-0.575x |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
-0.008x |
|
CK Power Public Company Limited
BK:CKP
|
0.040x |
|
Third Coast Bancshares, Inc.
NYSE:TCBX
|
-0.059x |
|
Lotte Chilsung Beverage
KO:005300
|
0.042x |
|
A&W Food Services of Canada
TO:AW
|
0.063x |
Annual Cash Flow Conversion Efficiency for Shanghai Sanyou Medical Co Ltd (2016–2024)
The table below shows the annual cash flow conversion efficiency of Shanghai Sanyou Medical Co Ltd from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Shanghai Sanyou Medical Co Ltd worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.05 Billion ≈ $299.80 Million |
CN¥10.96 Million ≈ $1.60 Million |
0.005x | -95.91% |
| 2023-12-31 | CN¥2.04 Billion ≈ $298.91 Million |
CN¥267.43 Million ≈ $39.13 Million |
0.131x | +60.58% |
| 2022-12-31 | CN¥1.91 Billion ≈ $279.93 Million |
CN¥155.97 Million ≈ $22.82 Million |
0.082x | -2.32% |
| 2021-12-31 | CN¥1.74 Billion ≈ $254.07 Million |
CN¥144.92 Million ≈ $21.21 Million |
0.083x | +65.21% |
| 2020-12-31 | CN¥1.53 Billion ≈ $224.53 Million |
CN¥77.52 Million ≈ $11.34 Million |
0.051x | -64.16% |
| 2019-12-31 | CN¥437.81 Million ≈ $64.07 Million |
CN¥61.72 Million ≈ $9.03 Million |
0.141x | +142.41% |
| 2018-12-31 | CN¥340.24 Million ≈ $49.79 Million |
CN¥19.79 Million ≈ $2.90 Million |
0.058x | -21.95% |
| 2017-12-31 | CN¥289.06 Million ≈ $42.30 Million |
CN¥21.54 Million ≈ $3.15 Million |
0.075x | -39.21% |
| 2016-12-31 | CN¥158.19 Million ≈ $23.15 Million |
CN¥19.39 Million ≈ $2.84 Million |
0.123x | -- |
About Shanghai Sanyou Medical Co Ltd
Shanghai Sanyou Medical Co., Ltd. researches, develops, manufactures, and sells orthopedics implants in China. The company offers spinal and trauma implants under Tytus and Sanyou brand. Its spinal products comprise anterior cervical plate, anterior thoracolumbar, posterior cervical, posterior thoracolumbar, and minimally invasive products; and trauma implants, including shoulder and elbow system… Read more